BioGaia
126 SEK +1,04%2 investorer følger denne virksomhed
BioGaia is a biotechnology company. The company develops, markets and sells probiotic products. The products are mainly based on the bacterium Lactobacillus, which has probiotic effects. Today, the company's products are sold around the global market. Research and development are conducted via the company's external network of research institutions and clinics. The head office is located in Stockholm.
Omsætning
-
EBIT %
-
P/E
34,81
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
BIOG B
Daglig lav / høj pris
123,4 / 127,5
SEK
Markedsværdi
12,72 mia. SEK
Aktieomsætning
5,64 mio. SEK
Volumen
45 t
Seneste videoer
Finanskalender
Delårsrapport
22.10.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
EQT | 11,1 % | 8,3 % |
Fjärde AP-fonden | 7,7 % | 5,8 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
BioGaia AB: Interim Management Statement January - June 2024
Annual General Meeting of BioGaia
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools